The Evolving Role of Tucatinib in HER2-Positive Metastatic Breast Cancer

home / investigator-perspectives / the-evolving-role-of-tucatinib-in-her2-positive-metastatic-breast-cancer

A key opinion leader discusses how the role tucatinib is evolving in the management of HER2-positive metastatic breast cancer.

HER2-Positive mBC Emerging Treatment Landscape

EP. 1: HER2-Positive mBC Emerging Treatment Landscape

Sara A. Hurvitz, MD
July 15th 2020

Watch

Currently Accepted Regimens: NCCN Guidelines

EP. 2: Currently Accepted Regimens: NCCN Guidelines

Sara A. Hurvitz, MD
July 15th 2020

Watch

HER2CLIMB FDA Approval

EP. 3: HER2CLIMB FDA Approval

Sara A. Hurvitz, MD
July 15th 2020

Watch

R/R HER2+ mBC Management During COVID-19 Pandemic

EP. 4: R/R HER2+ mBC Management During COVID-19 Pandemic

Sara A. Hurvitz, MD
July 15th 2020

Watch